MEDiterranean Diet-driven Detoxification of OPioid Addicted patiEnts (MED-DOPE)

The MED-DOPE (MEDiterranean diet-driven Detoxification of OPioid addicted patiEnts) study is a randomized controlled trial that aims to investigate the role of a nutritional intervention based on the principles of Mediterranean diet on craving, which is the primary outcome, and blood redox status of opioid-addicted patients under medication-assisted treatment with buprenorphine and methadone. In detail, the patients of the intervention group will consume three meals per day (i.e., breakfast, lunch and dinner) based on the principles of Mediterranean diet for 90 days. The patients of the control group will follow their normal nutritional habits. Craving as the primary outcome, quality of sleep and biochemical parameters such as blood redox status will be evaluated. It is hypothesized that the applied nutritional intervention will reduce craving, probably through the improvement of blood redox status, of the patients of the intervention group compared to the patients of the control group.

NCT Number	NCT07022782
Lead Sponsor	Aristidis Veskoukis Collaborators: Organization Against Drugs (OKANA)
Conditions	Opioid Addiction
Enrollment	40 participants
Start Date	2025-03-10
Primary Completion	2025-08-18 (estimated)
Study Completion	2026-05 (estimated)
Updated on ClinicalTrials.gov	2026-04-09